Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535-202 Long-term Follow-up Study in Obese Subjects
CTR20244009Phase 2Completed
- Sponsor
- Shandong Sende
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535 in obesity, sponsored by Shandong Sende. Started Oct 2024; status: completed.
02
Drugs
HRS-7535
03
Conditions
obesity
Beyond the preview
Go deeper on CTR20244009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244009.